Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus pethidine for prevention of post-cesarean shivering and pain
IRCT20201207049639N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac and pethidine in postoperative pain and postanesthetic shivering (PAS), sponsored by Urmia University of Medical Sciences. Primary endpoints: Shivering after cesarean section and Pain after cesarean section. Started Apr 2020; status: completed.
02
Drugs
ketorolacpethidine
03
Conditions
postoperative painpostanesthetic shivering (PAS)
Beyond the preview
Go deeper on IRCT20201207049639N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201207049639N2.